Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by India Globalization Capital, Inc.
IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
December 01, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for Second Fiscal Quarter Ended Sept. 30, 2022
November 01, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC
September 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Announces Results of its 2022 Annual Stockholders Meeting
September 12, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for the Quarter Ended June 30, 2022
August 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022
June 22, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
June 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
June 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits
April 18, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors
March 23, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for the December 31, 2021 Quarter
February 10, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
January 19, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
December 14, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
December 08, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
December 02, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for the September 30, 2021 Quarter
October 29, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Announces Results of its 2021 Annual Stockholders Meeting
October 15, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
September 07, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for the June 30, 2021, Quarter
August 11, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
July 22, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer’s Patients
June 23, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
June 14, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
June 07, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
May 14, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Tickers
IGC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.